Published in Obesity and Diabetes Week, February 2nd, 2004
This phase II, double-blind, placebo-controlled study will enroll approximately 60 type 2 diabetic patients whose blood glucose has not been adequately controlled with diet and exercise.
Patients will receive T131 or placebo once daily for 28 days. The effectiveness of T131 will be assessed by measuring...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.